Last 12 months
Inside the activity.
1 purchase rows · 78 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 1 | 25 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 20 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 21 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 21, 2026 Filed Aug 25, 2026 23:17 UTC |
Reilly Joseph JamesSee Remarks
|
SaleCommon Stock | 1,110 | $3.86 | $4,281.16 |
DisclosureSEC source: 0002044416-26-000008 · wk-form4_1787699872.xml · nonDerivative · entry 2 Reilly Joseph James · CIK 0002044416 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,854 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 23:17 UTC |
Reilly Joseph JamesSee Remarks
|
SaleCommon Stock | 2,872 | $3.86 | $11,077.02 |
DisclosureSEC source: 0002044416-26-000008 · wk-form4_1787699872.xml · nonDerivative · entry 1 Reilly Joseph James · CIK 0002044416 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,964 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 23:13 UTC |
Foster Eric DuaneChief Commercial Officer
|
SaleCommon Stock | 2,575 | $3.86 | $9,931.52 |
DisclosureSEC source: 0002034148-26-000007 · wk-form4_1787699594.xml · nonDerivative · entry 3 Foster Eric Duane · CIK 0002034148 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 409,410 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 23:13 UTC |
Foster Eric DuaneChief Commercial Officer
|
SaleCommon Stock | 3,389 | $3.86 | $13,071.03 |
DisclosureSEC source: 0002034148-26-000007 · wk-form4_1787699594.xml · nonDerivative · entry 2 Foster Eric Duane · CIK 0002034148 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 411,985 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 23:13 UTC |
Foster Eric DuaneChief Commercial Officer
|
SaleCommon Stock | 2,598 | $3.86 | $10,020.23 |
DisclosureSEC source: 0002034148-26-000007 · wk-form4_1787699594.xml · nonDerivative · entry 1 Foster Eric Duane · CIK 0002034148 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 415,374 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 23:09 UTC |
Williams Laura AChief Patient Officer
|
SaleCommon Stock | 1,734 | $3.86 | $6,687.86 |
DisclosureSEC source: 0001869194-26-000011 · wk-form4_1787699362.xml · nonDerivative · entry 4 Williams Laura A · CIK 0001869194 · Chief Patient Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 367,456 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 23:09 UTC |
Williams Laura AChief Patient Officer
|
SaleCommon Stock | 2,430 | $3.86 | $9,372.27 |
DisclosureSEC source: 0001869194-26-000011 · wk-form4_1787699362.xml · nonDerivative · entry 3 Williams Laura A · CIK 0001869194 · Chief Patient Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 369,190 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 23:09 UTC |
Williams Laura AChief Patient Officer
|
SaleCommon Stock | 3,089 | $3.86 | $11,913.96 |
DisclosureSEC source: 0001869194-26-000011 · wk-form4_1787699362.xml · nonDerivative · entry 2 Williams Laura A · CIK 0001869194 · Chief Patient Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 371,620 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 23:09 UTC |
Williams Laura AChief Patient Officer
|
SaleCommon Stock | 3,486 | $3.86 | $13,445.15 |
DisclosureSEC source: 0001869194-26-000011 · wk-form4_1787699362.xml · nonDerivative · entry 1 Williams Laura A · CIK 0001869194 · Chief Patient Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 374,709 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 23:19 UTC |
Hohenleitner SusanChief Financial Officer
|
SaleCommon Stock | 1,558 | $3.86 | $6,009.05 |
DisclosureSEC source: 0002093095-26-000007 · wk-form4_1787699976.xml · nonDerivative · entry 1 Hohenleitner Susan · CIK 0002093095 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 227,520 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 23:16 UTC |
Bishop John ESee Remarks
|
SaleCommon Stock | 2,469 | $3.86 | $9,522.69 |
DisclosureSEC source: 0001308911-26-000007 · wk-form4_1787699798.xml · nonDerivative · entry 2 Bishop John E · CIK 0001308911 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 317,095 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 23:16 UTC |
Bishop John ESee Remarks
|
SaleCommon Stock | 17,281 | $3.86 | $66,651.09 |
DisclosureSEC source: 0001308911-26-000007 · wk-form4_1787699798.xml · nonDerivative · entry 1 Bishop John E · CIK 0001308911 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 319,564 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 23:15 UTC |
Brady James ParkerChief Human Resources Officer
|
SaleCommon Stock | 13,160 | $3.86 | $50,756.80 |
DisclosureSEC source: 0002088887-26-000007 · wk-form4_1787699714.xml · nonDerivative · entry 2 Brady James Parker · CIK 0002088887 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 245,930 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 23:15 UTC |
Brady James ParkerChief Human Resources Officer
|
SaleCommon Stock | 1,976 | $3.86 | $7,621.23 |
DisclosureSEC source: 0002088887-26-000007 · wk-form4_1787699714.xml · nonDerivative · entry 1 Brady James Parker · CIK 0002088887 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 259,090 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 23:11 UTC |
Kelliher MikeChief Business Officer
|
SaleCommon Stock | 2,002 | $3.86 | $7,721.51 |
DisclosureSEC source: 0001987188-26-000009 · wk-form4_1787699487.xml · nonDerivative · entry 3 Kelliher Mike · CIK 0001987188 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 349,660 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 23:11 UTC |
Kelliher MikeChief Business Officer
|
SaleCommon Stock | 2,652 | $3.86 | $10,228.50 |
DisclosureSEC source: 0001987188-26-000009 · wk-form4_1787699487.xml · nonDerivative · entry 2 Kelliher Mike · CIK 0001987188 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 351,662 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 23:11 UTC |
Kelliher MikeChief Business Officer
|
SaleCommon Stock | 3,104 | $3.86 | $11,971.82 |
DisclosureSEC source: 0001987188-26-000009 · wk-form4_1787699487.xml · nonDerivative · entry 1 Kelliher Mike · CIK 0001987188 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 354,314 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 23:07 UTC |
RAAB MICHAELDirector · President & CEO
|
SaleCommon Stock | 19,178 | $3.86 | $73,967.63 |
DisclosureSEC source: 0001321402-26-000019 · wk-form4_1787699234.xml · nonDerivative · entry 4 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,619,792 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 23:07 UTC |
RAAB MICHAELDirector · President & CEO
|
SaleCommon Stock | 8,411 | $3.86 | $32,440.39 |
DisclosureSEC source: 0001321402-26-000019 · wk-form4_1787699234.xml · nonDerivative · entry 3 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,638,970 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 23:07 UTC |
RAAB MICHAELDirector · President & CEO
|
SaleCommon Stock | 15,976 | $3.86 | $61,617.83 |
DisclosureSEC source: 0001321402-26-000019 · wk-form4_1787699234.xml · nonDerivative · entry 2 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,647,381 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 23:07 UTC |
RAAB MICHAELDirector · President & CEO
|
SaleCommon Stock | 15,009 | $3.86 | $57,888.21 |
DisclosureSEC source: 0001321402-26-000019 · wk-form4_1787699234.xml · nonDerivative · entry 1 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,663,357 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. The transaction was executed in multiple trades in prices ranging from $3.648 to $3.984, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| July 15, 2026 Filed Jul 17, 2026 20:09 UTC |
RAAB MICHAELDirector · President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,834 | $0.00 Strike: $0.99 | $0.00 |
DisclosureSEC source: 0001321402-26-000016 · wk-form4_1784318944.xml · derivative · entry 5 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 290,834 Underlying: Common Stock · 20,834 shares Expires 2032-01-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025. F5 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| July 15, 2026 Filed Jul 17, 2026 20:09 UTC |
RAAB MICHAELDirector · President & CEO
|
SaleCommon Stock | 41,668 | $5.06 | $210,923.42 |
DisclosureSEC source: 0001321402-26-000016 · wk-form4_1784318944.xml · nonDerivative · entry 2 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,678,366 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025. F2 · price: Transaction was executed in multiple trades in prices ranging from $5.03 to $5.12, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| July 15, 2026 Filed Jul 17, 2026 20:09 UTC |
RAAB MICHAELDirector · President & CEO
|
Exercise / conversionCommon Stock | 20,834 | $0.99 | $20,625.66 |
DisclosureSEC source: 0001321402-26-000016 · wk-form4_1784318944.xml · nonDerivative · entry 1 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,720,034 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025. Read SEC document |
| June 18, 2026 Filed Jun 22, 2026 20:01 UTC |
Williams Laura AChief Patient Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 31,000 | $0.00 Strike: $0.99 | $0.00 |
DisclosureSEC source: 0001869194-26-000008 · wk-form4_1782158491.xml · derivative · entry 3 Williams Laura A · CIK 0001869194 · Chief Patient Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,000 Underlying: Common Stock · 31,000 shares Expires 2032-01-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 19, 2026. F3 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| June 18, 2026 Filed Jun 22, 2026 20:01 UTC |
Williams Laura AChief Patient Officer
|
SaleCommon Stock | 81,898 | $5.99 | $490,487.12 |
DisclosureSEC source: 0001869194-26-000008 · wk-form4_1782158491.xml · nonDerivative · entry 2 Williams Laura A · CIK 0001869194 · Chief Patient Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 378,195 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 19, 2026. F2 · price: Transaction was executed in multiple trades in prices ranging from $5.97 to $6.0086, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| June 18, 2026 Filed Jun 22, 2026 20:01 UTC |
Williams Laura AChief Patient Officer
|
Exercise / conversionCommon Stock | 31,000 | $0.99 | $30,690.00 |
DisclosureSEC source: 0001869194-26-000008 · wk-form4_1782158491.xml · nonDerivative · entry 1 Williams Laura A · CIK 0001869194 · Chief Patient Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 460,093 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 19, 2026. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:05 UTC |
Cadoret-Manier OnaizaDirector
|
GrantStock Option (Right to Buy) · Derivative | 39,715 | $0.00 Strike: $5.67 | $0.00 |
DisclosureSEC source: 0001799355-26-000006 · wk-form4_1781813140.xml · derivative · entry 2 Cadoret-Manier Onaiza · CIK 0001799355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,715 Underlying: Common Stock · 39,715 shares Expires 2036-06-16 F2 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program. F3 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:05 UTC |
Cadoret-Manier OnaizaDirector
|
GrantCommon Stock | 26,455 | $0.00 | $0.00 |
DisclosureSEC source: 0001799355-26-000006 · wk-form4_1781813140.xml · nonDerivative · entry 1 Cadoret-Manier Onaiza · CIK 0001799355 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,156 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) share of Common Stock for each one (1) RSU upon the vesting thereof. The RSUs were issued pursuant to the Issuer's Non-Employee Director Compensation Program. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 21:14 UTC |
Parsey MerdadDirector
|
GrantStock Option (Right to Buy) · Derivative | 39,715 | $0.00 Strike: $5.67 | $0.00 |
DisclosureSEC source: 0001792150-26-000002 · wk-form4_1781817269.xml · derivative · entry 2 Parsey Merdad · CIK 0001792150 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,715 Underlying: Common Stock · 39,715 shares Expires 2036-06-16 F2 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program. F3 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 21:14 UTC |
Parsey MerdadDirector
|
GrantCommon Stock | 26,455 | $0.00 | $0.00 |
DisclosureSEC source: 0001792150-26-000002 · wk-form4_1781817269.xml · nonDerivative · entry 1 Parsey Merdad · CIK 0001792150 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,746 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) share of Common Stock for each one (1) RSU upon the vesting thereof. The RSUs were issued pursuant to the Issuer's Non-Employee Director Compensation Program. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:08 UTC |
Rodgers Richard JDirector
|
GrantStock Option (Right to Buy) · Derivative | 39,715 | $0.00 Strike: $5.67 | $0.00 |
DisclosureSEC source: 0001313397-26-000002 · wk-form4_1781813313.xml · derivative · entry 2 Rodgers Richard J · CIK 0001313397 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,715 Underlying: Common Stock · 39,715 shares Expires 2036-06-16 F2 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program. F3 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:08 UTC |
Rodgers Richard JDirector
|
GrantCommon Stock | 26,455 | $0.00 | $0.00 |
DisclosureSEC source: 0001313397-26-000002 · wk-form4_1781813313.xml · nonDerivative · entry 1 Rodgers Richard J · CIK 0001313397 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 439,998 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) share of Common Stock for each one (1) RSU upon the vesting thereof. The RSUs were issued pursuant to the Issuer's Non-Employee Director Compensation Program. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:07 UTC |
MOTT DAVID MDirector
|
GrantStock Option (Right to Buy) · Derivative | 39,715 | $0.00 Strike: $5.67 | $0.00 |
DisclosureSEC source: 0001219871-26-000003 · wk-form4_1781813248.xml · derivative · entry 3 MOTT DAVID M · CIK 0001219871 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,715 Underlying: Common Stock · 39,715 shares Expires 2036-06-16 F4 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program. F5 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:07 UTC |
MOTT DAVID MDirector
|
GrantCommon Stock | 26,455 | $0.00 | $0.00 |
DisclosureSEC source: 0001219871-26-000003 · wk-form4_1781813248.xml · nonDerivative · entry 2 MOTT DAVID M · CIK 0001219871 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,349,655 F3 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) share of Common Stock for each one (1) RSU upon the vesting thereof. The RSUs were issued pursuant to the Issuer's Non-Employee Director Compensation Program. F2 · balance_after: The Reporting Person holds 87,566 shares for the benefit of entities associated with New Enterprise Associates and disclaims beneficial ownership of such shares, except to the extent of his actual pecuniary interest therein. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:07 UTC |
MOTT DAVID MDirector
|
GrantCommon Stock | 20,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001219871-26-000003 · wk-form4_1781813248.xml · nonDerivative · entry 1 MOTT DAVID M · CIK 0001219871 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,323,200 F1 · shares: The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program. The Reporting Person elected to receive stock in lieu of cash as permitted under the program. F2 · balance_after: The Reporting Person holds 87,566 shares for the benefit of entities associated with New Enterprise Associates and disclaims beneficial ownership of such shares, except to the extent of his actual pecuniary interest therein. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:04 UTC |
Bhanji MunaDirector
|
GrantStock Option (Right to Buy) · Derivative | 39,715 | $0.00 Strike: $5.67 | $0.00 |
DisclosureSEC source: 0001846905-26-000004 · wk-form4_1781813041.xml · derivative · entry 2 Bhanji Muna · CIK 0001846905 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,715 Underlying: Common Stock · 39,715 shares Expires 2036-06-16 F2 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program. F3 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:04 UTC |
Bhanji MunaDirector
|
GrantCommon Stock | 26,455 | $0.00 | $0.00 |
DisclosureSEC source: 0001846905-26-000004 · wk-form4_1781813041.xml · nonDerivative · entry 1 Bhanji Muna · CIK 0001846905 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,808 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) share of Common Stock for each one (1) RSU upon the vesting thereof. The RSUs were issued pursuant to the Issuer's Non-Employee Director Compensation Program. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:02 UTC |
Bertrand William C JRDirector
|
GrantStock Option (Right to Buy) · Derivative | 39,715 | $0.00 Strike: $5.67 | $0.00 |
DisclosureSEC source: 0001291937-26-000003 · wk-form4_1781812963.xml · derivative · entry 3 Bertrand William C JR · CIK 0001291937 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,715 Underlying: Common Stock · 39,715 shares Expires 2036-06-16 F3 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program. F4 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:02 UTC |
Bertrand William C JRDirector
|
GrantCommon Stock | 26,455 | $0.00 | $0.00 |
DisclosureSEC source: 0001291937-26-000003 · wk-form4_1781812963.xml · nonDerivative · entry 2 Bertrand William C JR · CIK 0001291937 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 329,507 F2 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) share of Common Stock for each one (1) RSU upon the vesting thereof. The RSUs were issued pursuant to the Issuer's Non-Employee Director Compensation Program. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:02 UTC |
Bertrand William C JRDirector
|
GrantCommon Stock | 12,345 | $0.00 | $0.00 |
DisclosureSEC source: 0001291937-26-000003 · wk-form4_1781812963.xml · nonDerivative · entry 1 Bertrand William C JR · CIK 0001291937 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 303,052 F1 · shares: The shares were issued pursuant to the Issuer's Non-Employee Director Compensation Program. The Reporting Person elected to receive stock in lieu of cash as permitted under the program. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:01 UTC |
Bazemore Robert BDirector
|
GrantStock Option (Right to Buy) · Derivative | 39,715 | $0.00 Strike: $5.67 | $0.00 |
DisclosureSEC source: 0001620152-26-000005 · wk-form4_1781812867.xml · derivative · entry 2 Bazemore Robert B · CIK 0001620152 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,715 Underlying: Common Stock · 39,715 shares Expires 2036-06-16 F2 · shares: The option was issued pursuant to the Issuer's Non-Employee Director Compensation Program. F3 · derivative.exercise_date: The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:01 UTC |
Bazemore Robert BDirector
|
GrantCommon Stock | 26,455 | $0.00 | $0.00 |
DisclosureSEC source: 0001620152-26-000005 · wk-form4_1781812867.xml · nonDerivative · entry 1 Bazemore Robert B · CIK 0001620152 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,006 F1 · shares: Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) share of Common Stock for each one (1) RSU upon the vesting thereof. The RSUs were issued pursuant to the Issuer's Non-Employee Director Compensation Program. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:01 UTC |
RAAB MICHAELDirector · President & CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,833 | $0.00 Strike: $0.99 | $0.00 |
DisclosureSEC source: 0001321402-26-000014 · wk-form4_1781726515.xml · derivative · entry 5 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 311,668 Underlying: Common Stock · 20,833 shares Expires 2032-01-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025. F5 · derivative.exercise_date: The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 6, 2022, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:01 UTC |
RAAB MICHAELDirector · President & CEO
|
SaleCommon Stock | 41,666 | $5.67 | $236,346.22 |
DisclosureSEC source: 0001321402-26-000014 · wk-form4_1781726515.xml · nonDerivative · entry 2 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,699,200 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025. F2 · price: Transaction was executed in multiple trades in prices ranging from $5.625 to $5.77, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:01 UTC |
RAAB MICHAELDirector · President & CEO
|
Exercise / conversionCommon Stock | 20,833 | $0.99 | $20,624.67 |
DisclosureSEC source: 0001321402-26-000014 · wk-form4_1781726515.xml · nonDerivative · entry 1 RAAB MICHAEL · CIK 0001321402 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,740,866 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025. Read SEC document |
| May 21, 2026 Filed May 22, 2026 20:18 UTC |
Reilly Joseph JamesSee Remarks
|
SaleCommon Stock | 1,036 | $6.27 | $6,493.13 |
DisclosureSEC source: 0002044416-26-000005 · wk-form4_1779481118.xml · nonDerivative · entry 2 Reilly Joseph James · CIK 0002044416 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,836 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. F2 · balance_after: Includes 1,765 shares acquired under the Issuer's employee stock purchase plan on February 27, 2026. Read SEC document |
| May 21, 2026 Filed May 22, 2026 20:18 UTC |
Reilly Joseph JamesSee Remarks
|
SaleCommon Stock | 2,683 | $6.27 | $16,815.70 |
DisclosureSEC source: 0002044416-26-000005 · wk-form4_1779481118.xml · nonDerivative · entry 1 Reilly Joseph James · CIK 0002044416 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,107 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| May 21, 2026 Filed May 22, 2026 20:12 UTC |
Foster Eric DuaneChief Commercial Officer
|
SaleCommon Stock | 2,405 | $6.27 | $15,073.34 |
DisclosureSEC source: 0002034148-26-000004 · wk-form4_1779480738.xml · nonDerivative · entry 3 Foster Eric Duane · CIK 0002034148 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 417,972 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
| May 21, 2026 Filed May 22, 2026 20:12 UTC |
Foster Eric DuaneChief Commercial Officer
|
SaleCommon Stock | 2,427 | $6.27 | $15,211.22 |
DisclosureSEC source: 0002034148-26-000004 · wk-form4_1779480738.xml · nonDerivative · entry 2 Foster Eric Duane · CIK 0002034148 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 420,377 F1 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.